Leukemia Mortality Trends in the United States, 1999-2018
Leukemia was the seventh most prevalent cause of mortality among cancer patients. It was...
Read More
Dissemination (Meeting Coverage)
Psychological Mobile App for Acute Myeloid Leukemia (AML) Patients
During their hospitalization for rigorous chemotherapy, patients with Acute Myeloid Leukemia (AML)...
Read More
Multiple Sclerosis: Epstein-Barr Virus & Herpes Simplex Viruses
While the cause of multiple sclerosis (MS) was unknown, evidence showed that herpesviruses (HVs),...
Read More
Predicting Satisfaction With Psychosocial Life in Patients With MS
Health professionals have urged studies to measure people’s “happiness” by...
Read More
Recognition & Awareness of Spasticity in MS
Even though spasticity is prevalent, persons with multiple sclerosis (MS) with spasticity (PwMSS)...
Read More
Use of Disease-Modifying Therapies by Women With MS
Women of reproductive age were more likely to be diagnosed with multiple sclerosis (MS). Although...
Read More
DMTs Lower Multiple Sclerosis Relapse Risk During Reproductive Therapy
In women with multiple sclerosis (MS) and clinically isolated syndrome (CIS), continuing disease...
Read More
Spinal Cord Atrophy Indicates “Silent Progression”
In patients in the earlier stages of MS, an accelerated rate of spinal cord atrophy can indicate...
Read More
Social Vulnerability Predicts Greater Multiple Sclerosis Disability
“It has previously been thought that [multiple sclerosis (MS)] is less common among non-European...
Read More
White Matter Iron Rim Lesions Predict Worse Disability in Multiple Sclerosis
“Identifying an accurate prognostic biomarker in individuals with multiple sclerosis (MS) is...
Read MorePlasma NfL levels associated with cardiovascular risk
Elevated levels of neurofilament light chain (NfL) are a known biomarker for neurodegeneration in conditions such as stroke, dementia, Multiple sclerosis, and Amyotrophic lateral sclerosis. A new study reveals that NfL may also...
Read More
Long-term Ozanimod Delivers No Evidence of Disease Activity in MS
Patients with relapsing multiple sclerosis (RMS) achieved No Evidence of Disease Activity (NEDA)...
Read More
Preoperative PET Scans Improve Management of Gynecologic Cancer
Preoperative PET scanning among patients with high-risk, clinical stage 1 endometrial cancer (EC)...
Read More
Immunotherapy Underutilized for Patients With Gynecologic Cancer
Immunotherapy is underutilized in patients with advanced endometrial cancer (EC), even though...
Read More
Increased Disparities Found in Cervical Cancer Screening Post-Pandemic
The COVID-19 pandemic had a major effect on access to gynecologic care for women of all races and...
Read More
BMI Impacts SLN Mapping in Gynecologic Cancer
Prior research has examined sentinel lymph node (SLN) mapping among patients with a range of BMI...
Read MoreAAN Schedule Highlights
April 2, 7:00 PM – 10:00 PM Industry Therapeutic Update from EMD Serono, Inc.: Early DMT switch considerations in MS and discussing the capacity to mount an immune response April 3, 5:00 PM – 5:30 PM AAN Leadership...
Read MoreAAN Covid-19 Safety Protocals
Proof of Vaccination + Mask Requirement All in-person attendees, exhibitors, press personnel, guests, and staff must complete the COVID-19 vaccination process with an acceptable vaccine and booster, if eligible, a minimum of 7...
Read More
Ozanimod Safe & Effective in DAYBREAK Open-Label Extension
For patients with multiple sclerosis (MS), ozanimod provides continued control of disease activity...
Read MoreStructural Brain Damage & Cognitive Impairment Association
In individuals with multiple sclerosis (MS), researchers sought to determine the role of cognitive dysfunction in motor disability and structural disease-related burden. About 81 healthy controls and 109 relapsing-remitting (RR)...
Read More